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Abstract
Few data are available on plasma redox responses to sulfur amino acid (SAA) loads. In this study, we had 2 aims: to
determine whether the SAA content of a meal affected postprandial plasma cysteine (Cys), cystine (CySS), or redox
potential (EhCySS) in humans and whether SAA intake level (adequate or inadequate) in the days preceding the meal
challenge affected these postprandial levels. Eight healthy individuals aged 18–36 y were equilibrated for 3 d to adequate
SAA, fed chemically defined meals without SAA for 5 d (inadequate SAA) and then fed isoenergetic, isonitrogenous meals
with adequate SAA for 5 d. On the first and last days with the chemically defined meals, a morningmeal containing 60% of
the daily food intake was given, and plasma Cys, CySS, and EhCySS were determined over an 8-h postprandial time
course. Following equilibration to adequate intake, provision of the meal with SAA resulted in increased plasma Cys and
CySS concentrations and more reduced plasma EhCySS compared with the postprandial values following the same meal
without SAA. Equilibration to inadequate SAA intake for the days preceding the meal challenge did not affect this
response. The magnitude of the difference in postprandial plasma EhCySS (10 mV) due to meal content of SAA was
comparable to those which alter physiologic signaling and/or are associated with disease risk. Consequently, the SAA
content of meals could affect physiologic signaling and associated disease mechanisms in the postprandial period by
changes in Cys, CySS, or EhCySS. J. Nutr. 140: 760–765, 2010.
Introduction
Cysteinyl residues of proteins in cell membranes undergo
reversible oxidation-reduction in response to the redox potential
(EhCySS
3 in mV)9 of the extracellular Cys/cystine (CySS) pool,
the predominant low molecular weight thiol/disulfide couple in
human plasma. A relatively oxidized EhCySS increases proin-
flammatory cytokine production in monocytes (1), expression of
cell adhesion molecules in endothelial cells (2,3), profibrotic
signaling in lung fibroblasts (4), and apoptosis in retinal pigment
epithelial cells (5). In contrast, a relatively reduced EhCySS
increases cell cycle gene expression in monocytes (6), trans-
forming growth factor-a signaling in Caco-2 cells, and cell
proliferation in monocytes, endothelial cells, retinal pigment
epithelial cells, and colon carcinoma Caco-2 cells (7,8).
Plasma EhCySS is more oxidized (positive) in association with
aging (9) and disease risk factors, including cigarette smoking
(10), chronic alcohol abuse (11), and anticancer therapy (12).
Increased plasma CySS concentration and/or oxidized plasma
EhCySS have been associated with human disease risk, e.g.
persistent atrial fibrillation (13), peripheral vascular disease
(14), and age-related macular degeneration (15). In vivo studies
in humans also show that oxidized thiol/disulfide redox poten-
tial is associated with increased carotid intima media thickness
(14), decreased flow-mediated dilation (16), reversible myocar-
dial perfusion defects (17), and persistent atrial fibrillation (13).
Thus, dietary factors affecting extracellular thiol/disulfide redox
potential in human plasma could be important in disease risk
and development.
Relatively little is known about the dietary factors affecting
EhCySS in vivo. In a previous cysteine (Cys) challenge study, we
showed that following an oral load of 3 g Cys without food, Cys
and CySS increased to a maximum at 1 h (18). The calculation of
EhCySS from these data shows that the redox potential becomes
more reduced by 40 mVat 1 h after Cys administration. A study
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of diurnal variation of glutathione and Cys in human plasma
showed that plasma EhCySS varied in an apparent meal-related
pattern, becoming transiently reduced 2–3 h after each meal and
maximally reduced at 2030, which was 3 h after the largest meal
(19). These data suggest that plasma Cys and EhCySS vary in the
postprandial period.
The present study was designed to determine whether the
presence of sulfur amino acids (SAA) in a meal affects
postprandial plasma Cys, CySS, or EhCySS in healthy adults.
The study used a semisynthetic, chemically defined diet based on
the studies of Young et al. (20,21), which allows specific changes
in Met and Cys content. Changes in plasma Cys, CySS, and
EhCySS were measured as a function of time for an 8-h period
following a meal containing adequate (U.S. mean consumption)
or no SAA content. Because the abundance of Cys dioxygenase
(CDO), a key catabolic enzyme for Cys, is regulated by the Cys
intake (22), the study was designed to also determine whether
postprandial responses to meal challenge were affected by prior
equilibration to insufficient SAA intake.
Materials and Methods
Materials. Sodium heparin, bathophenanthroline disulfonate sodium
salt, sodium iodoacetate, dansyl chloride, L-serine, Cys, CySS, and
sodium acetate trihydrate were from Sigma Chemical. g-Glutamylglu-
tamate was from MP Biomedicals. Boric acid, sodium tetraborate,
potassium tetraborate, perchloric acid, and acetic acid were reagent
grade and purchased locally. Methanol, acetone, and chloroform were
HPLC grade.
Human participants. This study was reviewed and approved by the
Emory Investigational Review Board and was performed in accordance
with the ethical guidelines outlined in the U.S. Health and Human
Services Policy for Protection of Human Research Subjects. A total of 8
volunteers, self-described as healthy, were recruited beginning January 1,
2005, by posting fliers in public locations in the Atlanta/Emory
University community. Following informed consent, all participants
were screened in the outpatient unit of the Emory University Hospital
General Clinical Research Center (GCRC), where a medical history and
physical examination, body height and weight, fasting standard blood
chemistry and hematology tests, and a urinalysis were performed (a
serum pregnancy test was also performed in females). Indirect calorim-
etry was used to determine resting energy expenditure, and energy
content of meals was based upon the daily energy requirement calculated
as 1.3 resting energy expenditure. Eligibility was established by the
absence of evidence of acute or chronic illness, no current smoking
history, and a BMI , 30.
Participants were scheduled to begin the study within 1 mo of
screening. Participants taking antioxidants, nutrient supplements (with
the exception of once-daily multivitamin-mineral supplements), or
acetaminophen were asked to discontinue these 2 wk prior to the onset
of the studies because of possible effects on EhCySS. Four study periods
(see Supplemental Fig. 1 for details) within a 13-d inpatient stay in the
Emory Hospital GCRC were used to determine whether meal content of
SAA had an effect on postprandial plasma Cys, CySS, and EhCySS and
whether adequate or inadequate SAA intake for the preceding 3 d
affected these plasma measures. The first study period began after 3 d of
equilibration with regular food containing the Recommended Dietary
Allowance for SAA, at which time the participant was given a meal
without SAA and studied for 8 h in the postprandial period. This study
period was designated the adequate/2SAA period (Supplemental Fig. 1).
The participant received food without SAA for the next 4 d and was
again studied in the postprandial period after receiving a meal without
SAA. This second period is designated the inadequate/2SAA period. On
the following day when the participant was still equilibrated to
inadequate SAA, the participant was given an isonitrogenous, isoener-
getic meal containing SAA; this period is designated the inadequate/
+SAA period. After 4 d with adequate intake, the participant was again
studied with a meal containing SAA; this period is designated the
adequate/+SAA period (Supplemental Fig. 1).
For each study period, a plasma sample was collected at 0830 h just
before provision of a meal consisting of 60% of the estimated total daily
energy requirement. Postprandial samples were collected at 0930, 1030,
1130, 1230, 1430, and 1630 h. The chemically defined diets contained
an L-amino acid mixture expressed per kg body weight to provide
1.0 g×kg21×d21 protein equivalents (see below). Study meals were
prepared in the GCRC metabolic kitchen and consumed over 20 min;
intake was monitored by the GCRC Bionutrition Unit staff.
Meal composition. The protein equivalents of diets were supplied in
the form of specific L-amino acid mixtures (Ajinomoto USA), designed to
provide 1.0 g×kg21×d21, as previously outlined in detail (20,21). The
standard mixture was patterned after hen’s egg protein and provided all
9 indispensable (essential) amino acids, including Met, in amounts
sufficient for the mean requirements of healthy young adults (20,21), but
which were higher than the requirements proposed by theWHO (21,23).
The standard amino acid mixture also contained 9 dispensable (nones-
sential) amino acids, including Cys and glutamate, and lacked gluta-
mine- and taurine. To compensate for the difference in Met + Cys, the
amount of all nonessential amino acids was proportionally changed to
maintain a constant dietary nitrogen content while also maintaining
them as isoenergetic. The proportion by weight of Met:Cys was constant
(2:1). To improve palatability, a powdered flavoring agent was added to
the liquid amino acid mixture (provided as a sherbet-based drink)
(20,21). The Cys was added immediately prior to consumption to
minimize Cys oxidation to CySS. The dietary energy was mainly derived
from lipid and carbohydrate sources provided in the form of protein-free
wheat starch and butter/safflower oil cookies and a sherbet-based drink,
as outlined (20,21).
Sampling and redox analyses
A heparin-lock catheter was placed in a forearm vein for blood sampling
(19) and plasma samples were collected at 0830 (just prior to the meal),
0930, 1030, 1130, 1230, 1440, and 1630, with immediate transfer into a
preservation solution containing in internal standard. Samples were
frozen at 2808 and analyzed by HPLC following derivatization with
dansyl chloride (24) within 2 mo of collection. Stability tests showed that
samples were stable for this duration. Cys and CySS were detected by
fluorescence and quantified by integration relative to the internal
standard, with validation relative to external standards (24). EhCySS
was calculated using the Nernst equation, Eh = Eo + RT/nF ln[CySS]/
([Cys]2), where Eo is the standard potential (2250 mV for CySS/Cys at
pH 7.4), R is the gas constant, T is the absolute temperature, n is 2 for the
number of electrons transferred, and F is Faraday’s constant (25). Protein
cysteinylation correlated with plasma CySS and was not measured in the
current study (25).
Kinetic constants. The rate constants for elimination (kElim) and the
apparent volumes of distribution (VD) were determined from the slope
and the y-intercept, respectively, of the semilogarithmic plot of plasma
concentrations of Cys and CySS as a function of time. The elimination
half-life (t1/2) was related to the kElim by the equation t1/2 = 0.693/kElim.
Metabolic clearance (CL) was calculated as the product kElim × VD.
Statistics. Descriptive statistics were performed using Minitab software
(version 15; Minitab). To compare the effects of time and SAA intake on
responses and their interaction, a repeated-measures ANOVA was
performed using R software (K. Hornik, The R FAQ, 2009, ISBN
3-900051-08-9, http://CRAN.R-project.org/doc/FAQ/R-FAQ.html) with
a mixed effects model. Paired t tests to compare group responses for
specific postchallenge time points were performed usingMinitab. Data are
expressed as mean 6 SEM and were considered significant at P , 0.05.
Results
Study participant characteristics
Eight participants aged 18–36 y were studied (Table 1),
including 5 males and 3 females with BMI ranging from 20 to
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26 kg×m22. The participants reported no acute or chronic illness
and none were taking regular prescription medications.
Postprandial effects with equilibration to adequate
SAA intake
Effect of meal Cys content on plasma Cys. At baseline, the
plasma Cys concentration was 9.9 6 1.5 mmol×L21 following
the 3-d equilibration (Fig. 1A). SAA intake (adequate/+SAA vs.
adequate/2SAA) affected Cys levels (P , 0.0001) by repeated-
measures ANOVA. During the adequate/+SAA period, plasma
Cys was maximal at 1 h (19 6 3 mmol×L21) (Fig. 1A). Plasma
Cys concentrations were significantly higher than the corre-
sponding time points in the adequate/2SAA period for 1-, 2-, 3-,
and 4-h time points, respectively (Fig. 1A).
Kinetic parameters during the adequate/+SAA period were
estimated from semilogarithmic plots of concentration vs. time
and showed that after achieving the maximal value, plasma Cys
decreased with an apparent first-order loss. The t1/2 was 36 0.2
h and VD was 190 6 30 L (Table 2). Assuming nearly complete
absorption into a blood volume of ~6 L, this high VD indicated a
rapid removal of Cys from the blood volume. Using the kElim
determined from the t1/2, the CL was 44 6 8 L×h
21 (Table 2).
Effect of meal Cys content on plasma CySS. At baseline, the
plasma CySS concentration following the 3-d equilibration was
78 6 5 mmol×L21 (Fig. 1B). SAA intake (adequate/+SAA vs.
adequate/2SAA) affected CySS levels (P , 0.0001). During the
adequate/+SAA period, CySS concentration increased achieving
a maximal value of 94 6 8 mmol×L21 at 3 h (Fig. 1B). The area
under the curve (AUC) for plasma CySS was 676 8 mmol×L21×h
(Table 2). When expressed in Cys equivalents, the value (134 6
16 mmol×L21×h) was greater than that for plasma Cys (47 6 12
mmol×L21×h) (P , 0.05; Table 2). This shows that following
consumption of a meal with Cys, a larger amount of the total
(Cys + CySS) pool is present in plasma as CySS than as Cys.
Because Cys was added to the meal immediately prior to
consumption and was confirmed by HPLC to be in the reduced
Cys form rather than CySS, these data show that extensive
oxidation of Cys occurs upon absorption into systemic circula-
tion. The kElim and CL values were lower for CySS than for Cys
(P , 0.05). Thus, in association with Cys consumption, a
relatively large fraction of the ingested Cys appears in circula-
tion as CySS, and this CySS is cleared more slowly than Cys.
Effect of meal Cys content on plasma EhCySS. At baseline,
the plasma EhCySS was 274 6 4 mV (Fig. 1C). There was a
significant effect of SAA intake (adequate/+SAA vs. adequate/
2SAA) (P , 0.0001), with the postchallenge data from the
adequate/+SAA period showing more reduced values than with
zero SAA (adequate/2SAA). Plasma EhCySS became reduced
(more negative) in the adequate/+SAA period, achieving a
maximally reduced value of 285 6 4 mV after 2 h (Fig. 1C).
This value was 10 mV more reduced than the fasting morning
value and 13 mV more reduced than the 2-h value in the
adequate/2SAA period (Fig. 1C). Thus, the results show that
plasma EhCySS becomes more reduced as a consequence of
consumption of food containing SAA at an amount found in
typical American diets.
Postprandial effects with equilibration to inadequate
SAA intake
Effect of meal SAA content on plasma Cys. At baseline, the
plasma Cys concentration was 8.0 6 1.0 mmol×L21 following
TABLE 1 Characteristics of the humans1
Males Females Total
Participants, n (%) 5 (62) 3 (38) 8
Age, y 25 6 6 25 6 8 25 6 6
Weight, kg 66 6 9 65 6 11 66 6 9
BMI 21 6 1 24 6 2 23 6 2
1 Data are means 6 SD.
FIGURE 1 Effect of meal SAA content on postprandial plasma Cys (A,D) and CySS (B,E) concentrations and EhCySS (C,F) in humans. Panels
A–C show values obtained following a meal containing SAA (+SAA) and an equivalent meal without SAA (2SAA) after equilibration with an
adequate SAA diet. Panels D–F are comparable data obtained after equilibration with an inadequate SAA diet. Values are means + SEM, n = 8.
*Different from 2SAA at that time, P , 0.05 (paired t test). For each panel, the effect of SAA was significant, P , 0.0001 (repeated-measures
ANOVA with a mixed effect model).
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equilibration to inadequate SAA intake (Fig. 1D). Under this
condition, SAA intake (inadequate/+SAA vs. inadequate/2SAA)
affected Cys levels by repeated-measures ANOVA (P, 0.0001).
During the inadequate/+SAA period, plasma Cys increased
following intake of the SAA-containing meal and was maximal
at 3 h (20 6 3 mmol×L21) (Fig. 1D). Plasma Cys concentrations
were significantly higher than the corresponding time points in
the inadequate/2SAA period for 2-, 3-, 4-, and 5-h time points,
respectively (Fig. 1D).
The AUC, kElim, and CL for Cys during the inadequate/+SAA
period did not significantly differ from values for the adequate/
+SAA period by paired t tests (Table 2), suggesting that any
potential changes in absorption and clearance or disposition due
to equilibration to an inadequate SAA intake had little effect on
plasma Cys responses to consumption of a meal with mean Cys
content.
Effect of SAA content in meal on plasma CySS. At baseline,
the plasma CySS concentration was 696 6 mmol×L21 following
the period of SAA depletion (Fig. 1E). SAA intake (inadequate/
+SAA vs. inadequate/2SAA) affected CySS levels (P , 0.0001).
CySS concentration increased during the inadequate/+SAA
period, achieving a maximal value of 89 6 6 mmol×L21 at 3 h
(Fig. 1E).
The AUC for CySS was 75 6 12 mmol×L21×h during the
inadequate/+SAA period; this did not differ from that for the
adequate/+SAA period (67 6 8 mmol×L21×h) (Table 2). The
estimated t1/2 was 4.1 6 0.6 h during the inadequate/+SAA
period (Table 2), less than the estimate for the adequate/+SAA
period (8.1 6 0.7 h) (Table 2) (P , 0.05). The kElim was greater
for the inadequate/+SAA period (0.15 6 0.02 h21) compared
with the adequate/+SAA period (0.096 0.01 h21) (Table 2) (P,
0.05).
Effect of meal Cys content on plasma EhCySS after
inadequate intake of SAA. At baseline, the plasma EhCySS
was2676 5 mV (Fig. 1F). There was a significant effect of SAA
intake (insufficient/+SAA vs. insufficient/2SAA) (P , 0.0001),
with the postchallenge inadequate/+SAA group showing more
reduced values than the inadequate/2SAA group. Plasma
EhCySS became more reduced in the inadequate/+SAA period,
achieving a maximally reduced value of 288 6 4 mV after 2 h
(Fig. 1F). This value was 20 mV more reduced than the fasting
morning value and 27 mV more reduced than the 2-h samples in
the inadequate/2SAA period (Fig. 1F).
Discussion
Glutathione is the most abundant low molecular weight thiol in
cells, but the amino acid Cys and its disulfide, CySS, constitute
the major low molecular weight thiol/disulfide system in human
plasma (26). A number of in vitro and in vivo studies suggest
that oxidation of the plasma Cys/CySS pool could be important
in human health. For instance, human cells in culture regulate
extracellular EhCySS in the culture medium to the value found in
plasma of young healthy adults (7). Controlled variation of
extracellular EhCySS in culture medium alters cell proliferation
(2,4,7,8,27), sensitivity of cells to oxidant-induced apoptosis (5),
adhesion of monocytes and neutrophils to endothelial cells (1,2),
and profibrotic signaling through transforming growth factor-b
(4). Cell surface thiols participate in these redox sensitivities,
because pretreatment with cell impermeable alkylating reagents
blocks redox effects (1,2,8). A more oxidized plasma EhCySS has
been associated with a number of disease risk factors (28).
The present study addressed whether SAA in food affected
plasma EhCySS. In individuals with a previous history of
adequate SAA intake, the plasma EhCySS without SAA was
10 mV more oxidized than the same meal with SAA. The
magnitude of meal-related changes in EhCySS in the present
study are similar to differences associated with aging (9,15),
smoking (10), alcohol consumption (11), and persistent atrial
fibrillation (13). Thus, the data suggest that in free-living
individuals eating diets with SAA at levels similar to the mean
American intake, the magnitude of change in EhCySS during the
postprandial period is sufficient to contribute to disease risk.
We focused on EhCySS in the present study, because previous
in vitro mechanistic research showed relevant redox effects on
cell signaling. However, some of the clinical studies provide
stronger associations of disease risk with CySS concentration
than with EhCySS (14,29,30). This creates a complexity in
interpretation, because earlier studies showed that diurnal
changes in EhCySS were largely associated with variations in
Cys concentration (19) whereas age-dependent oxidation of
EhCySS was largely associated with increased CySS (9). To
address critical questions concerning optimal SAA intake and
disease, additional studies are needed in older, at-risk individuals.
Research in rodents shows that high Cys intake activates Cys
catabolism by CDO (31–33). CDO levels in rats are responsive
to changes in SAA intake, reaching new steady-state levels
within 24 h (22). We designed the study in humans to test for
differences in metabolism between equilibration to adequate and
inadequate SAA intake. There were no significant differences
detected (compare Fig. 1A andD, Fig. 1B and E, Fig. 1C and F).
Thus, the data in these individuals suggest that plasma Cys and
EhCySS are most responsive to the current meal SAA content and
not the several days of previous SAA intake before the meal
challenges. More direct experiments will be needed to test the
role of CDO changes in adaptation of Cys metabolism to SAA
intake level in humans.
The kinetic data provided by the current study suggest that
tracer studies are needed to evaluate the plasma Cys flux to
TABLE 2 Kinetic constants for plasma Cys and CySS following
oral intake by humans of a meal containing SAA
(+SAA) and an equivalent meal without SAA





AUC, mmolL21h 47 6 12 51 6 12
Increase, mmolL21 14 6 3 16 6 3
VD, L 190 6 30 200 6 40
t1/2, h 3.0 6 0.2 4.0 6 1.0
kElim, h
21 0.23 6 0.01 0.20 6 0.03
CL, Lh21 44 6 8 40 6 12
Plasma CySS kinetics
AUC, mmolL21h 67 6 8 75 6 12
Mean plasma increase, mmolL21 18 6 3 20 6 2
VD, L 58 6 1 55 6 4
t1/2, h 8.1 6 0.7 4.1 6 0.6*
kElim, h
21 0.09 6 0.01 0.15 6 0.02*
CL, Lh21 5.4 6 0.8 8 6 1
1 Data are means 6 SE, n = 8. *Different from Adequate/+SAA, P , 0.05 (paired t
test). Other comparisons between Cys and CySS parameters are described in the text.
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plasma CySS as a separate component of the metabolic pathway
for Cys turnover (Fig. 2). The calculated VD for Cys (190–200 L)
shows that Cys was rapidly removed from plasma, which could
be due to transport into tissues and/or oxidation to CySS or
other products. Both the current study and a previous study (18)
indicate that a fraction of the Cys is converted to CySS over the
same time course as absorption. The AUC data for CySS show
that a substantial fraction of the absorbed Cys is oxidized to
CySS. Because the AUC for CySS (expressed in Cys equivalents)
was greater than the administered Cys load, the data indicate
that Met conversion to Cys also contributes to the overall
plasma CySS flux (Fig. 2). An estimate of CySS turnover
obtained from the mean AUC for the measured 8-h time course
was 18 mmol×kg21×h21, which is one-half of the Cys flux (38–80
mmol×kg21×h21), measured using stable isotopic tracer methods
(20,21,34). This, combined with the plasma concentration of
CySS being considerably greater than that of Cys, indicates that
kinetic models may be improved by the inclusion of oxidation of
Cys to CySS and tissue CySS uptake and reduction (i.e. steps 5–
7, Fig. 2).
One of the limitations of the current study is that the
clearance of Cys by oxidation and catabolism is confounded by
ongoing synthesis of Cys from Met, and tracer studies will be
needed to discriminate these processes. Another limitation is
that overall effects of negative nitrogen balance induced by the
absence of both Cys and Met in the diet devoid of SAA are
unclear.
In summary, the postprandial plasma EhCySS was more
reduced with a semisynthetic, chemically defined diet containing
SAA than an equivalent isoenergetic, isonitrogenous diet with-
out SAA. The magnitude of plasma redox changes during the
postprandial period due to SAA content of the food was similar
to previously reported variations in EhCySS associated with
aging, oxidative stress, and disease. Thus, the data suggest that
meal-related variations in EhCySS may be of a sufficient
magnitude to be considered in redox mechanisms of disease.
Acknowledgments
Y.P., D.J., and T.Z. participated in study design, analytic
supervision, data interpretation, and manuscript preparation.
Y.P. and T.Y. performed statistical analyses. N.G-M. partici-
pated in design detail, participant recruitment, and coordina-
tion of the clinical aspects of this study in collaboration with
T.Z. Y.L. participated in analytical design and amino thiol
analysis. C.A. participated in data interpretation and project
supervision. All authors read and approved of the final version
of this manuscript.
Literature Cited
1. Iyer SS, Accardi CJ, Ziegler TR, Blanco RA, Ritzenthaler JD, Rojas M,
Roman J, Jones DP. Cysteine redox potential determines pro-inflammatory
IL-1beta levels. PLoS One. 2009;4:e5017.
2. Go YM, Jones DP. Intracellular proatherogenic events and cell adhesion
modulated by extracellular thiol/disulfide redox state. Circulation.
2005;111:2973–80.
3. Essex DW, Li M. Redox control of platelet aggregation. Biochemistry.
2003;42:129–36.
4. Ramirez A, Ramadan B, Ritzenthaler JD, Rivera HN, Jones DP, Roman
J. Extracellular cysteine/cystine redox potential controls lung fibroblast
proliferation and matrix expression through upregulation of trans-
forming growth factor-beta. Am J Physiol Lung Cell Mol Physiol.
2007;293:L972–81.
5. Jiang S, Moriarty-Craige SE, Orr M, Cai J, Sternberg P Jr, Jones DP.
Oxidant-induced apoptosis in human retinal pigment epithelial cells:
dependence on extracellular redox state. Invest Ophthalmol Vis Sci.
2005;46:1054–61.
6. Go YM, Craige SE, Orr M, Gernert KM, Jones DP. Gene and protein
responses of human monocytes to extracellular cysteine redox potential.
Toxicol Sci. 2009;112:354–62.
7. Jonas CR, Ziegler TR, Gu LH, Jones DP. Extracellular thiol/disulfide
redox state affects proliferation rate in a human colon carcinoma
(Caco2) cell line. Free Radic Biol Med. 2002;33:1499–506.
8. Nkabyo YS, Go YM, Ziegler TR, Jones DP. Extracellular cysteine/cystine
redox regulates the p44/p42 MAPK pathway by metalloproteinase-
dependent epidermal growth factor receptor signaling. Am J Physiol
Gastrointest Liver Physiol. 2005;289:G70–8.
9. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr. Redox
analysis of human plasma allows separation of pro-oxidant events of
aging from decline in antioxidant defenses. Free Radic Biol Med.
2002;33:1290–300.
10. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, Jones DP, Sternberg
P. Oxidation of glutathione and cysteine in human plasma associated
with smoking. Free Radic Biol Med. 2003;35:1582–8.
11. Yeh MY, Burnham EL, Moss M, Brown LA. Chronic alcoholism alters
systemic and pulmonary glutathione redox status. Am J Respir Crit
Care Med. 2007;176:270–6.
12. Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, Bergman
GF, Furr CE, Tyre C, Carlson JL, et al. Plasma antioxidant status after
high-dose chemotherapy: a randomized trial of parenteral nutrition in
bone marrow transplantation patients. Am J Clin Nutr. 2000;72:181–9.
13. Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones
DP, Dudley SC Jr. Oxidative stress markers are associated with
persistent atrial fibrillation. Clin Chem. 2007;53:1652–7.
14. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper
WC, Vaccarino V, Harrison DG, Quyyumi AA. The relationship
between plasma levels of oxidized and reduced thiols and early
atherosclerosis in healthy adults. J Am Coll Cardiol. 2006;47:1005–11.
15. Moriarty-Craige SE, Adkison J, Lynn M, Gensler G, Bressler S, Jones
DP, Sternberg P Jr. Antioxidant supplements prevent oxidation of
cysteine/cystine redox in patients with age-related macular degenera-
tion. Am J Ophthalmol. 2005;140:1020–6.
16. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper
WC, Vaccarino V, Alexander RW, Harrison DG, et al. Endothelial
function and aminothiol biomarkers of oxidative stress in healthy
adults. Hypertension. 2008;52:80–5.
17. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub
WS, Harrison DG, Quyyumi AA, Vaccarino V. Association between
novel oxidative stress markers and C-reactive protein among adults
without clinical coronary heart disease. Atherosclerosis. 2005;178:
115–21.
18. Tribble DL, Jones DP, Ardehali A, Feeley RM, Rudman D. Hyper-
cysteinemia and delayed sulfur excretion in cirrhotics after oral cysteine
loads. Am J Clin Nutr. 1989;50:1401–6.
FIGURE 2 Minimal kinetic model for plasma EhCySS in humans.
The present data show that a large fraction of dietary Cys appears as
CySS in plasma. This reveals a need to incorporate steps 5–7 in
models for plasma Cys turnover. Thus, minimal components for
absorption and turnover of Cys include: 1) transepithelial transport of
Cys from the small intestine into the plasma; 2) reversible transport of
Cys from plasma into tissues; 3) biosynthesis of Cys from Met within
tissues; 4) catabolism and removal of Cys by CDO and other metabolic
pathways within tissues; 5) oxidation of Cys to CySS; 6) uptake of
CySS from plasma by tissues; and 7) reduction of CySS to Cys within
tissues. The changes in plasma EhCySS and the delay in clearance of
plasma CySS following meals with high SAA content indicate that
additional stable isotopic tracer studies are needed to evaluate the
rates of steps 5–7 separately from steps 2–4.
764 Park et al.
19. Blanco RA, Ziegler TR, Carlson BA, Cheng PY, Park Y, Cotsonis
GA, Accardi CJ, Jones DP. Diurnal variation in glutathione and
cysteine redox states in human plasma. Am J Clin Nutr. 2007;86:
1016–23.
20. Lyons J, Rauh-Pfeiffer A, Yu YM, Lu XM, Zurakowski D, Tompkins
RG, Ajami AM, Young VR, Castillo L. Blood glutathione synthesis rates
in healthy adults receiving a sulfur amino acid-free diet. Proc Natl Acad
Sci USA. 2000;97:5071–6.
21. Raguso CA, Regan MM, Young VR. Cysteine kinetics and oxidation at
different intakes of methionine and cystine in young adults. Am J Clin
Nutr. 2000;71:491–9.
22. Lee JI, Londono M, Hirschberger LL, Stipanuk MH. Regulation of
cysteine dioxygenase and gamma-glutamylcysteine synthetase is associ-
ated with hepatic cysteine level. J Nutr Biochem. 2004;15:112–22.
23. Di Buono M, Wykes LJ, Ball RO, Pencharz PB. Dietary cysteine reduces
the methionine requirement in men. Am J Clin Nutr. 2001;74:761–6.
24. Jones DP. Redox potential of GSH/GSSG couple: assay and biological
significance. Methods Enzymol. 2002;348:93–112.
25. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, Sternberg P. Redox
state of glutathione in human plasma. Free Radic Biol Med.
2000;28:625–35.
26. Moriarty-Craige SE, Jones DP. Extracellular thiols and thiol/disulfide
redox in metabolism. Annu Rev Nutr. 2004;24:481–509.
27. Jonas CR, Gu LH, Nkabyo YS, Mannery YO, Avissar NE, Sax HC,
Jones DP, Ziegler TR. Glutamine and KGF each regulate extracellular
thiol/disulfide redox and enhance proliferation in Caco-2 cells. Am J
Physiol Regul Integr Comp Physiol. 2003;285:R1421–9.
28. Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8:
1865–79.
29. Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page
S, Mora AL, Brigham KL, Jones DP, Roman J, et al. Oxidation of
extracellular cysteine/cystine redox state in bleomycin-induced lung
fibrosis. Am J Physiol Lung Cell Mol Physiol. 2009;296:L37–45.
30. Moriarty-Craige SE, Ha KN, Sternberg P Jr, Lynn M, Bressler S, Gensler
G, Jones DP. Effects of long-term zinc supplementation on plasma thiol
metabolites and redox status in patients with age-related macular
degeneration. Am J Ophthalmol. 2007;143:206–11.
31. Dominy JE Jr, Hirschberger LL, Coloso RM, Stipanuk MH. Regulation
of cysteine dioxygenase degradation is mediated by intracellular
cysteine levels and the ubiquitin-26 S proteasome system in the living
rat. Biochem J. 2006;394:267–73.
32. Dominy JE Jr, Simmons CR, Hirschberger LL, Hwang J, Coloso RM,
Stipanuk MH. Discovery and characterization of a second mammalian
thiol dioxygenase, cysteamine dioxygenase. J Biol Chem. 2007;282:
25189–98.
33. Stipanuk MH, Ueki I, Dominy JE Jr, Simmons CR, Hirschberger LL.
Cysteine dioxygenase: a robust system for regulation of cellular cysteine
levels. Amino Acids. 2009;37:55–63.
34. Fukagawa NK, Ajami AM, Young VR. Plasma methionine and cysteine
kinetics in response to an intravenous glutathione infusion in adult
humans. Am J Physiol. 1996;270:E209–14.
Postprandial plasma cysteine/cystine redox potential 765
